Should you buy JPMorgan (JPM) stock in 2026?
2026-07-09 · By Lubin Danilo, founder of Lubin Investment
JPM: see the full analysis on Lubin Investment
JPMorgan Chase meets 7 of my 10 quality criteria and trades at a price that looks cheap for a bank this size. But my fair price calculation, stricter than a single ratio, sets the bar above the current price. Here is why I am not buying yet, despite a business I consider genuinely strong.
The bank everyone watches, for good reason
JPMorgan Chase is not just another bank. It is the largest bank in the United States by assets, a heavyweight of the Dow Jones, and the kind of company analysts cite first when they want to take the pulse of the American financial system. With a market cap close to 837 billion dollars, it alone is worth more than the GDP of many countries.
When a stock this size runs through my screener with a score of 7 out of 10, it deserves attention. Not because the score is perfect, it is not. But because a global bank meeting 7 out of 10 objective criteria is rare. Most large banks I have screened cap out lower.
Profitability that stands out
The first number that jumps out: a net margin of 33.3%. Out of 100 dollars of revenue, JPMorgan keeps 33 as net profit. Few companies, across any sector, reach that level. For a bank, it signals a well oiled machine: controlled funding costs, scale effects, and revenue diversified across retail banking, investment banking and asset management.
The cash conversion rate even tops 250%, a figure that looks odd at first glance. That is a quirk of banks: their balance sheet is made of financial assets and liabilities, not factories or inventory, so free cash flow (the cash left after investments) behaves differently than at an industrial company. I note the number, but I stay careful about what it truly means for a financial institution. I always cross check it against net margin and balance sheet quality.
The weak spot: cash per share is shrinking
Here is what concerns me more. Over five years, JPMorgan's free cash flow per share has fallen by an average of 47.2% a year. That is the only criterion that fails outright in my screener. Revenue growth, meanwhile, runs at 7.7% a year, below my 10% threshold, so it lands in warning territory rather than outright failure.
Two possible explanations, and I have no certainty which dominates: an unusually high comparison base five years ago (US banks enjoyed years of very favorable trading and interest rate conditions), and heavier capital consumption in recent years to meet new regulatory capital requirements. What I do note: JPMorgan keeps buying back its own stock, at a pace of 2.01% a year, which limits the damage for shareholders even as total cash growth slows.
The moat: sheer scale
JPMorgan's moat, its durable competitive advantage, comes down to one word: scale. A massive, low cost deposit base, proprietary technology the bank pours billions into every year that smaller rivals cannot match, and systemic status that reassures institutional clients in times of stress. When Bear Stearns and First Republic wobbled, JPMorgan is who bought them, not the other way around.
On management, the bank has a track record of capital discipline: a steady dividend, constant buybacks, and a reputation for risk prudence that held up reasonably well through past crises. That is not a final verdict, no bank is immune to a credit accident, but it is a reassuring point on management quality.
The price: cheap on one measure, expensive on another
This is where the story gets interesting. On the P/FCF criterion, the share price divided by the cash generated each year, JPMorgan trades at 5.6 times its free cash flow. My tolerance threshold sits at 25 times, so JPMorgan sits comfortably under it, one of the lowest valuations I see on a global bank.
But my fair buy price, which factors in more than this single ratio (growth trajectory, balance sheet quality, a margin of safety), lands at 275.86 dollars. The stock trades today around 335 dollars, nearly 22% above that threshold. The ratio says cheap, my fair price calculation says not yet. The two do not contradict each other, they simply measure different things: P/FCF compares price to this year's cash generation, while the fair buy price tries to anticipate whether that cash keeps growing, slows down, or shrinks, as just happened with FCF per share.
| Criterion | JPMorgan | My threshold |
|---|---|---|
| P/FCF | 5.6 times | under 25 times |
| Net margin | 33.3% | positive |
| FCF per share (5 years) | -47.2%/year | over 10%/year |
| Fair buy price | $275.86 | current price: $335.47 |
The July 14 results: a test worth watching
JPMorgan reports second quarter results on July 14, 2026, before markets open. Consensus expects earnings of 5.74 dollars per share. Last quarter, the bank beat estimates by 8%, posting 5.94 dollars against 5.50 expected. This will be a chance to see whether the five year decline in cash per share reflects a real structural slowdown or simply a base effect fading out.
I never bet on a single quarterly print. What I watch is whether the underlying trend, margins, credit loss provisions, trading revenue, confirms or contradicts the concern raised by the FCF per share criterion.
How I am calling it
JPMorgan remains, in my view, a high quality company: profitable, well run, with a genuine moat. But quality does not mean buying at any price. As long as the stock stays above my 275.86 dollar threshold, I consider it does not yet offer the margin of safety I look for, despite a P/FCF that looks attractive at first glance. I would rather wait for a pullback, or a clear improvement in the cash per share trend, than rely on the one ratio that, on this particular stock, tells a slightly too optimistic story. To dig into the full numbers, the JPMorgan analysis page breaks down every criterion, and my full methodology explains how I separate quality from price.
- JPMorgan meets 7 of my 10 quality criteria, a rare score for a global bank.
- Net margin of 33.3% and steady buybacks (-2.01%/year), but free cash flow per share has fallen 47.2% a year over 5 years.
- P/FCF of 5.6 times looks cheap (threshold at 25 times), but my fair buy price of $275.86 sits below the current $335.47 price.
- Next earnings on July 14, 2026, consensus at $5.74 earnings per share.
- I view the stock as a quality business, but not yet at the right price by my method.
FAQ
Why does JPMorgan's P/FCF look so low?
Because banks have a different free cash flow profile than industrial companies: their balance sheet is financial, not physical. A low P/FCF at a bank does not automatically mean it is undervalued, which is why I always pair this ratio with a fair buy price that factors in more variables.
Is the decline in free cash flow per share worrying?
It is the weak spot in the score. A 47.2% annual decline over 5 years is significant, even though buybacks cushion the impact for shareholders. I will watch the coming quarters to see if the trend stabilizes.
When does JPMorgan report next?
On July 14, 2026, before markets open, with a consensus of $5.74 earnings per share for the second quarter.
Is JPMorgan a buy right now by my method?
Not yet, based on my fair buy price of $275.86, while the stock trades around $335. The business quality is real, but I do not buy a good company at any price.
Does JPMorgan pay a dividend?
Yes, a quarterly dividend of $1.50 per share as of the latest known quarter, rising steadily over the years, on top of constant share buybacks.
JPM: see the full analysis on Lubin Investment
About the author
Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).